Initial analysis revealed that about 2 to 4% of the bulk CD34bright and CD34dim cells expressed CD235a, but there was no difference between the healthy and the three SCD treatment groups (Figure 4A). The gene discussed is GYPA; the disease is Schnyder corneal dystrophy.